Mediolanum International Funds’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Mediolanum International Funds's PFE Position: Q2 2026 in Review
Mediolanum International Funds reduced its Pfizer (PFE) stake by 47% in Q2 2026, selling an estimated $17.1M and leaving 720,894 shares worth $17.6M. The position accounts for 0.15% of the portfolio, ranked #157.
Mediolanum International Funds first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.1M in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Mediolanum International Funds held 720,894 shares of Pfizer worth $17.6M as of Q2 2026.
- Mediolanum International Funds sold 652,204 Pfizer shares in Q2 2026, an estimated $17.1M.
- Pfizer made up 0.15% of Mediolanum International Funds's portfolio in Q2 2026, its #157 holding.
- Mediolanum International Funds first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
- Mediolanum International Funds's Pfizer position peaked at $38.1M in Q1 2026.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.